Like peers, narrow-moat Kimberly-Clark has been inundated by a slew of challenges, including a tepid economic environment and elevated cost pressures. In this context, management has been forthright ...

NEENAH, Wis. (WLUK) -- It's an iconic product known around the world that has become synonymous with facial tissue. We're talking about Kleenex -- and its impact on the papermaking industry in ...

Kimberly-Clark, is acquiring Tylenol's parent company Kenvue in a cash and stock deal worth nearly 50 billion, creating a massive consumer health products company. The Kimberly-Clark conglomerate, ...

Kimberly-Clark Corporation (NASDAQ:KMB) produces personal care, tissue, and hygiene products for consumer and professional use. During the November 4 episode, Cramer discussed the company’s earnings ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

On Monday, Kimberly-Clark, the company behind Kleenex, Huggies and Kotex, agreed to acquire Kenvue, the owner of Tylenol, Band-Aid and Neutrogena, in a cash and stock deal valued at approximately ...

We believe Kimberly-Clark has a narrow economic moat based on intangible assets, reflecting the entrenched retailer relationships it has built as well as its portfolio of brands that span multiple ...

DALLAS (AP) -- Consumer products company Kimberly-Clark Corp. announced Wednesday that Senior Vice President and Chief Marketing Officer Tony Palmer has been named president for global brands and ...

Kimberly-Clark is making a big move with a nearly $50 billion deal. The North Texas company plans to acquire Kenvue Inc., a personal care product provider with brands like Tylenol, in a deal that ...